MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CRL — Charles River Laboratories International, Inc.
NYSECharles River Laboratories International, Inc.
$290.19
+3.36(+1.17%)
- O
- 287.91
- H
- 290.61
- L
- 285.75
- V
- 434.21K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CRL
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
SectorNot available
IPO DateJun 23, 2000
Employees19,700
Stock ExchangeNYSE
Ticker SymbolCRL
Websitehttps://www.criver.com
Key Financial Statistics
| Market Cap | $13.98B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $146.20 - $303.31 |
| 52-Week Avg Volume | 922.9K |
| VWAP | $288.99 |
| Transactions | 13,788 |
| Total Recorded Bars | 6,607 days |